Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
12/20/1995 | EP0687249A1 Balanoids |
12/20/1995 | EP0687182A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
12/20/1995 | EP0687181A1 Method of treating hepatitis c in non-responders to interferon treatment |
12/20/1995 | EP0687179A1 Use of antiepileptics such as carbamazepine and oxcarbazepine for treating aids-related neural disorders |
12/20/1995 | EP0687177A1 Use of lamotrigine for treating aids-related neural disorders |
12/20/1995 | EP0687176A1 Use of riluzole for treating aids-related neural disorders |
12/20/1995 | EP0533833B1 Phosphorous produgs |
12/20/1995 | EP0180581B2 Drug preparations of reduced toxicity |
12/20/1995 | CN1113518A A novel peptide related to human programmed cell death and DNA encoding it |
12/19/1995 | US5476950 Aminopyrrolidine compound |
12/19/1995 | US5476930 Thiophosphorylacetylamino linkage; reacting a thiophosphate compound with a bromoacetylamino compound |
12/19/1995 | US5476874 New HIV protease inhibitors |
12/19/1995 | US5476856 Treatment of PAF and histamine-mediated diseases with 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
12/19/1995 | US5476855 Enzyme inhibitors, their synthesis and methods for use |
12/19/1995 | US5476843 Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic |
12/19/1995 | US5476841 Peptide |
12/19/1995 | US5476784 Medical diagnosis |
12/19/1995 | US5476778 Method of growing and attenuating a viral agent associated with mystery swine disease |
12/19/1995 | US5476669 Administering a bismuth compound, a first antibiotic from tetracycline and penicillin groups and a second antibiotic which is metronidazole; for preventing recurrence of duodenal ulcer |
12/19/1995 | US5476658 Vaccine against hepatitis a comprising simian HAV isolate AGM-27 |
12/19/1995 | US5476657 Pasteurella haemolytica leukotoxin compositions and uses thereof |
12/19/1995 | CA2069869C Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages |
12/19/1995 | CA1337782C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation |
12/19/1995 | CA1337781C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation |
12/19/1995 | CA1337760C Antibacterial and antitumor agents ll-e33288e-i and ll-e33288e-br, with processes and intermediates for producing said agents |
12/19/1995 | CA1337759C Glycopeptide antibiotic |
12/19/1995 | CA1337758C Peptide antibiotics |
12/18/1995 | CA2149197A1 Production of an efficacious toxoplasma gondii bradyzoite vaccine in tissue culture |
12/14/1995 | WO1995033835A1 Nucleic acid immunization using a virus-based infection/transfection system |
12/14/1995 | WO1995033772A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
12/14/1995 | WO1995033767A1 Helicobacter pylori nickel binding protein |
12/14/1995 | WO1995033752A1 Endothelin receptor antagonists |
12/14/1995 | WO1995033750A1 Corticotropin releasing factor antagonists |
12/14/1995 | WO1995033495A1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
12/14/1995 | WO1995033491A1 Biotin compounds for targetting tumors and sites of infection |
12/14/1995 | WO1995033482A1 Treatment and prevention of helicobacter infection |
12/14/1995 | WO1995033481A1 Diphtheria toxin vaccines bearing a mutated r domain |
12/14/1995 | WO1995033470A1 Composition for dental use comprising krill enzyme |
12/14/1995 | WO1995033467A2 Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications |
12/14/1995 | WO1995033464A2 Retroviral protease inhibitor combinations |
12/14/1995 | WO1995033459A1 Use of a naphthalenesulfonic acid compound for inhibiting retroviral infection |
12/14/1995 | CA2192384A1 Biotin compounds for targetting tumors and sites of infection |
12/14/1995 | CA2192312A1 Helicobacter pylori nickel binding protein |
12/14/1995 | CA2191960A1 Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications |
12/14/1995 | CA2191948A1 Retroviral protease inhibitor combinations |
12/14/1995 | CA2191362A1 Nucleic acid immunization using a virus-based infection/transfection system |
12/14/1995 | CA2191239A1 Diphtheria toxin vaccines bearing a mutated r domain |
12/13/1995 | EP0686642A2 Modified guanidino and amidino thrombin inhibitors |
12/13/1995 | EP0686402A1 Collagen membrane for preventing post-surgical adhesions |
12/13/1995 | EP0686151A1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
12/13/1995 | EP0686148A1 Inhibitors of hiv reverse transcriptase |
12/13/1995 | EP0686143A1 Unsaturate amino compounds for use as anticancer and antiprotozoic agent |
12/13/1995 | EP0686032A1 Use of 2-chloro-1- 4- (2,6-dichlorophenoxy)methyl]-phenyl]methoxy]-4-methoxy-benzene for the selective treatment of enteroviral infections in humans |
12/13/1995 | CN1113390A Defective adenovirus vectors and use thereof in gene therapy |
12/13/1995 | CN1113244A Novel process |
12/13/1995 | CN1113243A 8-amino-10-(azabicycloalkyl)-pyrido(1,2,3,-D,E)(1,3,4) benzoxadiazine derivatives |
12/13/1995 | CN1113241A Antifungal agents, processes for the preparation thereof, and intermediates |
12/13/1995 | CN1113237A N-(2-amino-4,6-pyrimidine bichloride-5-) formamide and preparation of same |
12/13/1995 | CN1113233A A method for producing a pyrrolidire derivative |
12/13/1995 | CN1113228A A process for preparing the intermediate of the derivatives of monocycle beta-lactam antibiotics |
12/12/1995 | US5475094 Salmycins, a process for their preparation and their use as a pharmaceutical |
12/12/1995 | US5475092 Deliver cytotoxic drugs to specific cell population in targeted fashion |
12/12/1995 | US5475087 Polypeptides |
12/12/1995 | US5475010 Vaginal infections |
12/12/1995 | US5474997 Methods and compositions of (2R,4S) itraconazole for treating fungal yeast and dermatophyte infections |
12/12/1995 | US5474995 Phenyl heterocycles as cox-2 inhibitors |
12/12/1995 | US5474987 Methods of using low molecular weight heparins treatment of pathological processes |
12/12/1995 | US5474986 Method for treating galabiose-binding bacteria infections |
12/12/1995 | US5474932 Prophylaxis and treatment of bacterial infections |
12/12/1995 | US5474914 Method of producing secreted CMV glycoprotein H |
12/12/1995 | US5474774 Adhesion inhibiting composition |
12/12/1995 | US5474773 Human rotaviruses, vaccines and method |
12/12/1995 | US5474771 Inhibits T cell activation of B cells ; binds to epitope |
12/12/1995 | CA2005365C Medication for the treatment or prevention of hiv virus infection through passive immunization and processes for its preparation |
12/12/1995 | CA1337717C Monoclonal antibodies against human necrosis factor (tnf) _ use thereof for detecting tnf in samples, and pharmaceutical compositions containing them |
12/11/1995 | CA2151412A1 Modified guanidino and amidino thrombin inhibitors |
12/07/1995 | WO1995033053A1 Hepatitis c virus asialoglycoproteins |
12/07/1995 | WO1995033049A2 Tbp2 FRAGMENTS OF THE TRANSFERRINE RECEPTOR OF NEISSERIA MENINGITIDIS |
12/07/1995 | WO1995032986A1 Branched oligonucleotides as pathogen-inhibitory agents |
12/07/1995 | WO1995032984A1 New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
12/07/1995 | WO1995032983A1 Post exposure prevention of hiv |
12/07/1995 | WO1995032982A1 Dna encoding gls1 |
12/07/1995 | WO1995032980A1 Synthesis of oligonucleotides |
12/07/1995 | WO1995032971A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF |
12/07/1995 | WO1995032970A1 (a)-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
12/07/1995 | WO1995032733A1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
12/07/1995 | WO1995032728A1 Inhibition of attachment of h. influenzae to human cells |
12/07/1995 | WO1995032727A1 Inhibition of infection of mammalian cells by respiratory syncytial virus |
12/07/1995 | WO1995032712A1 Compounds and compositions for administration via oral inhalation or insufflation |
12/07/1995 | WO1995024485A3 Coordinate in vivo gene expression |
12/07/1995 | DE4419315A1 New hetero- and oxo-pyrrolizine derivs. |
12/07/1995 | DE4419246A1 New hetero-aryl substd. pyrrolizine derivs. |
12/07/1995 | CA2191745A1 [a]-annelated pyrrole derivatives and pharmaceutical uses thereof |
12/07/1995 | CA2191067A1 Dna encoding gls1 |
12/07/1995 | CA2190998A1 Branched oligonucleotides as pathogen-inhibitory agents |
12/07/1995 | CA2190862A1 Post exposure prevention of hiv |
12/07/1995 | CA2190610A1 Inhibition of attachment of h. influenzae to human cells |
12/07/1995 | CA2190609A1 Inhibition of infection of mammalian cells by respiratory syncytial virus |
12/07/1995 | CA2190265A1 Hepatitis c virus asialoglycoproteins |
12/07/1995 | CA2167936A1 Tbp2 fragments of the transferrine receptor of neisseria meningitidis |